|
PIGB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.402150E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.225800E-04 |
| Normal-vs-Stage2 |
7.184500E-04 |
| Normal-vs-Stage3 |
5.055300E-03 |
| Normal-vs-Stage4 |
7.426700E-04 |
| Stage1-vs-Stage2 |
2.745200E-01 |
| Stage1-vs-Stage3 |
8.348000E-01 |
| Stage1-vs-Stage4 |
3.867200E-01 |
| Stage2-vs-Stage3 |
2.641200E-01 |
| Stage2-vs-Stage4 |
8.305800E-01 |
| Stage3-vs-Stage4 |
3.534600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.0579000000005E-05 |
| Normal-vs-AfricanAmerican |
8.465600E-01 |
| Normal-vs-Asian |
1.557940E-03 |
| Caucasian-vs-AfricanAmerican |
2.781800E-02 |
| Caucasian-vs-Asian |
8.599800E-01 |
| AfricanAmerican-vs-Asian |
4.539600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.132100E-02 |
| Normal-vs-Female |
4.01939999999934E-05 |
| Male-vs-Female |
6.592400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.848100E-04 |
| Normal-vs-Age(41-60Yrs) |
6.980700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.342200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.260600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.603600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.016800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.796600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.846800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.050200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.008800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.310000E-02 |
| Classical-VS-Follicular |
4.022200E-01 |
| Classical-VS-Other |
9.934600E-01 |
| Classical-VS-Normal |
1.299500E-03 |
| Tall-VS-Follicular |
2.356400E-02 |
| Tall-VS-Other |
2.864800E-01 |
| Tall-VS-Normal |
4.22279999999775E-05 |
| Follicular-VS-Other |
6.359400E-01 |
| Follicular-VS-Normal |
8.021600E-02 |
| Other-VS-Normal |
1.429830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.403800E-04 |
| Normal-vs-N1 |
6.43359999999982E-05 |
| N0-vs-N1 |
1.489960E-01 |
|
|
